NEWARK, Del., USA | March 13, 2026 — According to Future Market Insights (FMI), the global buttermilk phospholipids market is projected to grow from USD 306.2 million in 2026 to USD 618.5 million by 2036, registering a CAGR of 7.3% during the forecast period. Growth is being driven by increasing demand for biologically active dairy lipids in infant nutrition, dietary supplements, and functional food formulations.

The market expansion reflects a significant shift among pediatric nutrition manufacturers toward dairy-derived milk fat globule membrane (MFGM) ingredients that closely mimic the lipid architecture of human breast milk. Buttermilk phospholipids are increasingly replacing conventional soy lecithins in premium infant formula applications due to their clinically validated cognitive and immune health benefits.

FMI analysis indicates that powder form will dominate the product form segment with a 62.4% market share in 2026, supported by superior oxidative stability, improved shelf life, and seamless integration into dry-blend manufacturing systems. Meanwhile, infant formula is expected to lead the application segment with a 38.6% share, reflecting growing demand for biomimetic nutritional formulations.

“Demand for functional dairy lipids will continue to rise, but the industry faces a fundamental production limitation because buttermilk phospholipids are directly tied to global butter output,” said Nandini Roy Choudhury, Principal Analyst, Food and Beverage at FMI. “As pediatric nutrition brands aggressively scale their requirements for advanced dairy lipids, they are entering a structurally constrained supply environment that will sustain premium pricing and intensify competition for long-term supply contracts.”

Key Takeaways from the Buttermilk Phospholipids Market Study

·         The global buttermilk phospholipids market is forecast to reach USD 618.5 million by 2036.

·         The market is projected to expand at a CAGR of 7.3% between 2026 and 2036.

·         Powder form is anticipated to account for 62.4% of total market share in 2026.

·         Infant formula is expected to dominate the application segment with 38.6% share.

·         B2B direct sales are projected to lead distribution channels with 74.2% market share.

·         India is expected to emerge as the fastest-growing market, expanding at a CAGR of 10.2% through 2036.

·         China and Brazil are projected to grow at CAGR rates of 9.4% and 8.1%, respectively.

Rising Demand for Biomimetic Infant Nutrition Supporting Market Growth

The increasing emphasis on early-life cognitive and immune development is encouraging infant formula manufacturers to incorporate dairy phospholipids that replicate the structural functionality of human breast milk. Unlike plant-based lecithins, buttermilk phospholipids contain sphingomyelin and specialized milk fat globule membrane structures essential for neurological development.

Ongoing pediatric clinical studies validating the role of MFGM ingredients in brain development and immune support are strengthening adoption across tier-1 pediatric nutrition brands. Manufacturers are increasingly leveraging these clinically substantiated benefits to secure premium positioning in competitive retail markets.

Powder Formats Continue to Dominate Due to Superior Stability

Powdered buttermilk phospholipids are expected to remain the preferred format due to their enhanced oxidative stability during global transportation and long-term storage. Powder processing effectively protects delicate lipid fractions from rancidity while supporting integration into existing powder-handling systems across food manufacturing facilities.

In addition to improving handling efficiency, powder formats significantly reduce logistics costs by eliminating excess water weight, enabling global sourcing from specialized dairy ingredient hubs.

Direct B2B Partnerships Shape Distribution Landscape

FMI analysis reveals that direct B2B sales dominate the market because dairy phospholipid formulations require highly customized extraction and purification specifications tailored to specific end-use applications. Manufacturers and formulation scientists rely on direct collaboration to ensure precise phospholipid ratios, uninterrupted chain-of-custody documentation, and compliance with stringent pediatric safety standards.

Long-term procurement contracts are increasingly becoming essential as buyers seek protection against supply disruptions linked to fluctuating butter production volumes.

India and China Emerging as High-Growth Markets

India is projected to register the fastest growth at 10.2% CAGR through 2036, supported by rapid modernization of dairy processing infrastructure and increased investment in advanced membrane filtration technologies. The consolidation of fragmented dairy cooperatives is enabling commercial recovery of previously underutilized buttermilk streams.

China is anticipated to grow at 9.4% CAGR as domestic dairy conglomerates accelerate investments in specialized lipid extraction technologies to support national infant nutrition self-sufficiency initiatives. Updated pediatric nutrition standards are further encouraging manufacturers to transition away from legacy soy lecithin formulations.

Competitive Landscape

The buttermilk phospholipids market remains highly consolidated due to the technical complexity of extracting biologically active dairy lipids and the requirement for direct integration with large-scale butter production infrastructure.

Leading companies operating in the market include:

·         Fonterra Co-operative Group Limited

·         Arla Foods Ingredients Group P/S

·         Royal FrieslandCampina N.V.

·         Lactalis Ingredients

·         Valio Ltd.

·         Glanbia Nutritionals

·         Agropur Dairy Cooperative

·         Epi Ingredients

These companies continue to strengthen their market positions through investments in advanced ultrafiltration systems, specialized lipid extraction capabilities, and long-term supply agreements with pediatric nutrition manufacturers.

👉 Get Access to the Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-32310

Buttermilk Phospholipids Market Segmentation

By Product Form:

·         Powder

·         Liquid

·         Granules

By Application:

·         Infant Formula

·         Dietary Supplements

·         Functional Foods

·         Cosmetics

By Distribution Channel:

·         B2B Direct Sales

·         Distributor Networks

·         Online Platforms

By Region:

·         North America

·         Latin America

·         Western Europe

·         Eastern Europe

·         Asia Pacific

·         Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) provides in-depth market intelligence and strategic consulting services across industries including food & beverage, chemicals, healthcare, consumer goods, and industrial applications. FMI delivers forward-looking insights and actionable recommendations to help organizations navigate evolving market dynamics and identify growth opportunities.

Contact Us

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA

T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com